ADR Report-Banks lead rise in foreign stocks, drugs weigh
NEW YORK, April 3 (Reuters) - Overseas shares traded in the United States rose on Friday, marking their fourth straight week of gains, as a rise in banks and carmakers more than offset declines in pharmaceuticals.
Shares of foreign automakers rose after Credit Suisse upgraded the sector to "overweight" from "marketweight" in a global strategy review. New York-traded shares of Germany's Daimler (DAI.N: Quote, Profile, Research) shot up 8 percent while Japan's Toyota Motor Corp (TM.N: Quote, Profile, Research) and Nissan Motor NSANY.O added more than 4 percent each.
In a boost to financial shares, Morgan Stanley said most European banks appearing at a conference this week said they were profitable in the first quarter, aided by more lively capital markets and slower-than-expected credit deterioration.
Wall Street shares of Spain's Santander (STD.N: Quote, Profile, Research) rose 4.4 percent to $8.10, and Deutsche Bank (DB.N: Quote, Profile, Research) added 2.2 percent to $48.58.
Royal Bank of Scotland (RBS.N: Quote, Profile, Research) shot up 15.6 percent to $9.42 after it announced more job cuts. [ID:nL3113004]
But pharmaceutical companies declined, led by Novo Nordisk (NVO.N: Quote, Profile, Research), down 7.8 percent to $44.19 after a U.S. advisory panel failed to back the Danish company's experimental diabetes drug Victoza due to worries over cancer. [ID:nN02286714]
France's Sanofi Aventis (SNY.N: Quote, Profile, Research) fell 2.7 percent to $27.83 and Basel-based Novartis (NVS.N: Quote, Profile, Research) lost 2.1 percent to $37.51.
The Bank of New York Mellon's index of leading American Depositary Receipts (ADRs) rose 0.8 percent while the U.S. benchmark S&P 500 index .SPX gained 1 percent. Continued...
© Thomson Reuters 2009. All rights reserved. | Learn more about Thomson Reuters
